Lapatinib for advanced breast cancer overexpressing HER2
Loading...
Files
External sources
External sources
Date
Advisor
Coadvisor
Graduate program
Undergraduate course
Journal Title
Journal ISSN
Volume Title
Publisher
Type
Article
Access right
Files
External sources
External sources
Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the effectiveness and safety of lapatinib, used alone or in association with other drugs, improves the survival and the quality of life of woman with advanced breast cancer that overexpress the Human Epidermal Growth Factor Receptor 2 (HER2).
Description
Keywords
Language
English
Citation
Cochrane Database of Systematic Reviews, v. 2016, n. 9, 2016.
